Literature DB >> 27042497

Study the Impact of Diabetes Camps on Adherence to Medication and Glycaemic Control in Uttarakhand.

Monika Pathania1, Hemant Kumar Dutt2, Javin Bisnu Gogoi3, Vyas Rathaur4, Ganesh Singh5, Parul Singh6.   

Abstract

INTRODUCTION: Diabetes is a major public health problem which needs to be addressed with outmost planning in resource poor settings. Good glycaemic control and medication adherence patterns can play an important role in reducing disease related complications thereby reducing morbidity and mortality among diabetics. Disease specific camps can act as a stepping stone in providing limited care to the patients. AIM: The study was planned to study the impact of diabetes camp on glycaemic control and adherence to antidiabetic medication among diabetic patients at a Government Teaching Hospital, Srinagar, Garhwal, Uttarakhand, India.
MATERIALS AND METHODS: A cross-sectional study using a medication adherence questionnaire collected from the patients participating in diabetic camps and measuring their HbA1C levels before and after the camps along with spreading awareness about the disease. Two diabetes awareness camps were organized, three month apart and the participants were imparted knowledge about the disease. A total of 50 patients with type 2 DM who had self reported history of diabetes and were on some form of oral anti diabetics confirmed by their prescriptions. The patients were called for monthly follow up in outpatient department. A six question preformed questionnaire - the Girerd's instrument was used to assess the level of adherence to the prescribed anti-diabetic drugs in 50 patients with type 2 diabetes mellitus, their HbA1C levels were estimated and the results were analysed using standard statistical methods.
RESULTS: A total of 50 type 2 diabetic, 48 were studied comprising 23 (47.9%) women and 25 (52.1%) men with a mean age of 57.43 years. The average duration of diabetes among participants was 7.02 years. Poor medication adherence score was recorded in 27 participants and only 7 participants had good adherence to medication before the camp. After the camp, 19 participants had good adherence and 7 had poor medication adherence scores. As a result of improved adherence, improvement in glycaemic control was noticed by a decrease of 0.5 units in the mean HbA1C value by the end of the study.
CONCLUSION: The results clearly showed that group intervention in the form of camp combined with monthly follow-ups could improve adherence as well as glycaemic control at a government teaching hospital in a resource poor setting. This could also involve and encourage society as well as young trainees to participate collectively in the care of diabetics.

Entities:  

Keywords:  Anthropometry; Compliance; Disease specific camps; Girerd scale; Knowledge

Year:  2016        PMID: 27042497      PMCID: PMC4800563          DOI: 10.7860/JCDR/2016/16053.7271

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  Convergence of prevalence rates of diabetes and cardiometabolic risk factors in middle and low income groups in urban India: 10-year follow-up of the Chennai Urban Population Study.

Authors:  Mohan Deepa; Ranjit Mohan Anjana; Datta Manjula; K M Venkat Narayan; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

2.  [Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic].

Authors:  X Girerd; O Hanon; K Anagnostopoulos; C Ciupek; J J Mourad; S Consoli
Journal:  Presse Med       Date:  2001 Jun 16-23       Impact factor: 1.228

3.  Patients' adherence to diabetes treatment.

Authors:  R Shobhana; R Begum; C Snehalatha; V Vijay; A Ramachandran
Journal:  J Assoc Physicians India       Date:  1999-12

Review 4.  Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.

Authors:  Richard R Rubin
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors.

Authors:  Joan N Kalyango; Erisa Owino; Agatha P Nambuya
Journal:  Afr Health Sci       Date:  2008-06       Impact factor: 0.927

7.  Medication adherence and associated hemoglobin A1c in type 2 diabetes.

Authors:  Kimberley Krapek; Kathleen King; Susan S Warren; Karen G George; Dorothy A Caputo; Karen Mihelich; Elizabeth M Holst; Michael B Nichol; Sheng G Shi; Kevin B Livengood; Steve Walden; Teresa J Lubowski
Journal:  Ann Pharmacother       Date:  2004-07-06       Impact factor: 3.154

8.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

9.  Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study.

Authors:  Michel Tiv; Jean-François Viel; Frédéric Mauny; Eveline Eschwège; Alain Weill; Cécile Fournier; Anne Fagot-Campagna; Alfred Penfornis
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

10.  Level and determinants of diabetes knowledge in patients with diabetes in Zimbabwe: a cross-sectional study.

Authors:  Esther Mufunda; Kerstin Wikby; Albin Björn; Katarina Hjelm
Journal:  Pan Afr Med J       Date:  2012-12-12
View more
  2 in total

1.  Quality of life perception in type 2 diabetes.

Authors:  Cristian Petri; Laura Stefani; Vittorio Bini; Nicola Maffulli; Stefania Frau; Gabriele Mascherini; Massimiliano De Angelis; Giorgio Galanti
Journal:  Transl Med UniSa       Date:  2016-11-01

2.  Self-care behaviours among people with type 2 diabetes mellitus in South Asia: A systematic review and meta-analysis.

Authors:  Grish Paudel; Corneel Vandelanotte; Padam K Dahal; Tuhin Biswas; Uday N Yadav; Tomohiko Sugishita; Lal Rawal
Journal:  J Glob Health       Date:  2022-08-03       Impact factor: 7.664

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.